— Know what they know.
Not Investment Advice
Also trades as: GRAH (OTC)

AHR NYSE

American Healthcare REIT, Inc.
1W: -2.0% 1M: +5.0% 3M: -3.5% YTD: +6.1% 1Y: +43.9%
$50.19
+0.06 (+0.12%)
 
Weekly Expected Move ±5.1%
$44 $47 $49 $52 $54
NYSE · Real Estate · REIT - Healthcare Facilities · Alpha Radar Neutral · Power 51 · $9.7B mcap · 191M float · 1.29% daily turnover · Short 56% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
37.4 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 4.6%
Cost Advantage
48
Intangibles
14
Switching Cost
43
Network Effect
30
Scale ★
60
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AHR has No discernible competitive edge (37.4/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. ROIC of 4.6% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$58
Avg Target
$58
High
Based on 13 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$58.50
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-03-12 Truist Financial Michael Lewis $52 $57 +5 +9.3% $52.13
2026-03-02 Goldman Sachs Initiated $60 +14.9% $52.24
2026-01-29 BMO Capital Juan Sanabria Initiated $55 +18.7% $46.33
2026-01-20 Truist Financial Michael Lewis $53 $52 -1 +8.3% $48.01
2025-11-26 Truist Financial $46 $53 +7 +7.0% $49.51
2025-11-20 Morgan Stanley $52 $55 +3 +11.0% $49.56
2025-11-17 Morgan Stanley Ronald Kamdem Initiated $52 +8.6% $47.87
2025-10-17 JMP Securities $35 $50 +15 +17.7% $42.47
2025-10-14 KeyBanc $28 $43 +15 +4.1% $41.29
2025-09-19 UBS Initiated $51 +20.0% $42.49
2025-08-28 Scotiabank Initiated $47 +10.2% $42.66
2025-08-26 Truist Financial Michael Lewis $29 $46 +17 +8.2% $42.50
2025-08-13 RBC Capital Michael Carroll Initiated $45 +11.2% $40.47
2025-04-28 Jefferies Joe Dickstein Initiated $37 +18.9% $31.11
2025-03-04 JMP Securities Initiated $35 +14.6% $30.54
2024-11-15 Truist Financial Michael Lewis $27 $29 +2 +9.4% $26.51
2024-09-20 Truist Financial Michael Lewis $22 $27 +5 +4.4% $25.85
2024-09-19 KeyBanc Austin Wurschmidt $27 $28 +1 +9.1% $25.66
2024-09-16 KeyBanc Austin Wurschmidt Initiated $27 +9.8% $24.58
2024-09-03 Truist Financial Michael Lewis $17 $22 +5 +5.1% $20.93
2024-06-28 Truist Financial Michael Lewis $16 $17 +1 +16.4% $14.61
2024-04-03 Truist Financial Michael Lewis Initiated $16 +13.5% $14.10

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
3
ROE
2
ROA
2
D/E
4
P/E
1
P/B
5
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AHR receives an overall rating of B. Strongest factors: D/E (4/5), P/B (5/5). Areas of concern: ROE (2/5), ROA (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-20 B+ B
2026-05-08 B- B+
2026-03-30 C+ B-
2026-03-02 C C+
2026-03-02 C- C
2026-02-26 C C-
2026-02-02 C+ C
2026-01-30 C C+
2026-01-03 C- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

56 Grade B
Profitability
12
Balance Sheet
48
Earnings Quality
82
Growth
65
Value
38
Momentum
92
Safety
65
Cash Flow
65
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AHR scores highest in Momentum (92/100) and lowest in Profitability (12/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.76
Grey Zone
Piotroski F-Score
6/9
Beneish M-Score
-10.94
Unlikely Manipulator
Ohlson O-Score
-9.08
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 60.7/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 3.21x
Accruals: -4.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AHR scores 2.76, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AHR scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AHR's score of -10.94 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AHR's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AHR receives an estimated rating of BBB+ (score: 60.7/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). AHR's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
93.71x
PEG
0.08x
P/S
4.08x
P/B
0.00x
P/FCF
37.64x
P/OCF
27.54x
EV/EBITDA
28.52x
EV/Revenue
4.36x
EV/EBIT
74.06x
EV/FCF
43.90x
Earnings Yield
1.13%
FCF Yield
2.66%
Shareholder Yield
2.04%
Graham Number
$14.57
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 93.7x earnings, AHR is priced for high growth expectations. Graham's intrinsic value formula yields $14.57 per share, 245% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.280
NI / EBT
×
Interest Burden
0.561
EBT / EBIT
×
EBIT Margin
0.059
EBIT / Rev
×
Asset Turnover
0.478
Rev / Assets
×
Equity Multiplier
1.776
Assets / Equity
=
ROE
3.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AHR's ROE of 3.6% is driven by Asset Turnover (0.478), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.28 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$4.54
Price/Value
10.40x
Margin of Safety
-939.54%
Premium
939.54%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with AHR's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. AHR trades at a 940% premium to its adjusted intrinsic value of $4.54, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 93.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 575 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$50.20
Median 1Y
$89.92
5th Pctile
$56.87
95th Pctile
$142.19
Ann. Volatility
26.6%
Analyst Target
$58.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Danny Prosky
Chief Executive Officer and President
$800,000 $4,355,829 $6,685,948
Brian S. Peay
Chief Financial Officer
$525,000 $1,707,006 $3,208,370
Gabriel M. Willhite
Chief Operating Officer
$475,000 $1,141,916 $2,485,105
Stefan K.L. Oh
Chief Investment Officer
$440,000 $1,059,502 $2,265,432
Mark E. Foster
Executive Vice President, General Counsel and Secretary
$395,000 $765,189 $1,629,834

CEO Pay Ratio

Insufficient data for pay ratio.

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
121
+6.1% YoY
Revenue / Employee
$18,678,702
Rev: $2,260,123,000
Profit / Employee
$576,909
NI: $69,806,000
SGA / Employee
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -0.3% -0.2% -0.5% -1.7% -2.3% -1.9% 1.5% 2.5% 3.6% 3.59%
ROA -0.1% -0.0% -0.1% -0.8% -0.9% -0.7% 0.6% 1.4% 2.0% 2.02%
ROIC 0.5% -0.1% 1.8% 2.7% 2.9% 3.2% 14.0% 5.1% 4.6% 4.63%
ROCE 1.1% 2.2% 3.1% 2.7% 2.2% 2.1% 2.4% 2.1% 2.6% 2.57%
Gross Margin 19.2% 20.2% 20.4% 20.7% 20.0% 21.4% 20.7% 0.1% -1.3% -1.32%
Operating Margin 5.5% 6.3% 7.1% 7.4% 7.4% 8.5% 7.4% 6.6% 6.5% 6.51%
Net Margin -0.8% 0.4% -0.8% -5.9% -1.3% 1.8% 9.8% 1.8% 3.6% 3.64%
EBITDA Margin 17.7% 17.9% 15.6% 10.2% 12.5% 15.6% 14.8% 13.8% 16.8% 16.80%
FCF Margin -5.2% 1.5% 3.6% 4.1% 7.1% 7.1% 12.2% 10.0% 9.9% 9.94%
OCF Margin -1.2% 5.3% 7.6% 8.5% 11.5% 11.8% 13.6% 13.0% 13.6% 13.58%
ROE 3Y Avg snapshot only 0.30%
ROA 3Y Avg snapshot only 0.29%
ROIC 3Y Avg snapshot only 1.04%
ROIC Economic snapshot only 4.57%
Cash ROA snapshot only 5.93%
Cash ROIC snapshot only 6.71%
CROIC snapshot only 4.91%
NOPAT Margin snapshot only 9.36%
Pretax Margin snapshot only 3.31%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 1.77%
SBC / Revenue snapshot only 0.71%
Valuation
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -373.55 -959.17 -561.15 -113.13 -115.25 -179.45 251.07 112.48 88.36 93.713
P/S Ratio 2.91 1.83 2.22 2.07 2.22 2.74 3.11 3.47 3.74 4.081
P/B Ratio 1.14 1.44 2.67 1.89 2.08 2.60 3.03 2.36 2.67 0.003
P/FCF -56.26 121.73 62.38 50.83 31.41 38.44 25.43 34.87 37.64 37.643
P/OCF 34.33 29.07 24.29 19.34 23.10 22.91 26.67 27.54 27.540
EV/EBITDA 50.18 26.94 24.47 19.25 22.00 26.54 29.52 29.07 28.52 28.520
EV/Revenue 8.87 4.79 4.17 2.93 3.07 3.57 3.93 4.13 4.36 4.362
EV/EBIT 131.39 70.83 66.65 64.70 84.43 100.94 102.76 81.78 74.06 74.057
EV/FCF -171.42 319.15 117.16 72.15 43.42 50.16 32.10 41.41 43.90 43.902
Earnings Yield -0.3% -0.1% -0.2% -0.9% -0.9% -0.6% 0.4% 0.9% 1.1% 1.13%
FCF Yield -1.8% 0.8% 1.6% 2.0% 3.2% 2.6% 3.9% 2.9% 2.7% 2.66%
PEG Ratio snapshot only 0.078
Price/Tangible Book snapshot only 3.130
EV/OCF snapshot only 32.119
EV/Gross Profit snapshot only 45.574
Acquirers Multiple snapshot only 60.427
Shareholder Yield snapshot only 2.04%
Graham Number snapshot only $14.57
Leverage & Solvency
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 0.20 0.20 0.20 0.37 0.37 0.37 0.37
Quick Ratio 0.19 0.19 0.19 0.35 0.35 0.35 0.35
Debt/Equity 2.38 2.38 2.38 0.83 0.83 0.83 0.83 0.48 0.48 0.478
Net Debt/Equity 2.34 2.34 2.34 0.79 0.79 0.79 0.79 0.44 0.44 0.444
Debt/Assets 0.66 0.66 0.66 0.42 0.42 0.42 0.42 0.29 0.29 0.293
Debt/EBITDA 34.20 16.90 11.61 5.93 6.34 6.47 6.39 4.95 4.38 4.383
Net Debt/EBITDA 33.71 16.66 11.44 5.69 6.08 6.20 6.13 4.59 4.07 4.066
Interest Coverage 0.93 1.01 0.98 0.73 0.67 0.72 0.87 1.33 1.71 1.710
Equity Multiplier 3.60 3.60 3.60 1.98 1.98 1.98 1.98 1.63 1.63 1.634
Debt Service Coverage snapshot only 4.440
Cash to Debt snapshot only 0.072
FCF to Debt snapshot only 0.148
Defensive Interval snapshot only 2089.1 days
Efficiency & Turnover
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.11 0.22 0.33 0.46 0.47 0.47 0.49 0.46 0.48 0.478
Inventory Turnover 20.73 41.40 62.82 84.92 86.40 87.62 89.54 196.79 220.10 220.100
Receivables Turnover 2.69 5.42 8.24 9.81 10.65 10.84 11.09 10.88 11.41 11.412
Payables Turnover 1.66 3.32 5.04 6.40 6.71 6.81 6.96 14.84 16.60 16.595
DSO 135 67 44 37 34 34 33 34 32 32.0 days
DIO 18 9 6 4 4 4 4 2 2 1.7 days
DPO 220 110 72 57 54 54 52 25 22 22.0 days
Cash Conversion Cycle -67 -34 -22 -15 -16 -16 -15 11 12 11.6 days
Fixed Asset Turnover snapshot only 8.746
Operating Cycle snapshot only 33.6 days
Cash Velocity snapshot only 20.641
Capital Intensity snapshot only 2.289
Growth (YoY)
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3.2% 1.1% 43.9% 9.1% 12.2% 12.24%
Net Income -9.5% -16.1% 5.5% 2.8% 3.5% 3.46%
EPS -6.0% -12.9% 4.7% 2.7% 3.1% 3.06%
FCF 6.8% 9.2% 4.0% 1.7% 57.6% 57.60%
EBITDA 2.3% 62.0% 12.5% 1.7% 22.9% 22.95%
Op. Income 4.4% 1.8% 75.1% 23.5% 14.5% 14.46%
OCF Growth snapshot only 32.65%
Asset Growth snapshot only 20.90%
Equity Growth snapshot only 46.85%
Debt Growth snapshot only -15.07%
Shares Change snapshot only 19.79%
Dividend Growth snapshot only 18.73%
Growth Quality
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.85 0.851
Earnings Stability 0.51 0.507
Margin Stability 0.64 0.639
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 1 1 1 1 0
Earnings Persistence 0.20 0.200
Earnings Smoothness
ROE Trend 0.04 0.041
Gross Margin Trend -0.10 -0.102
FCF Margin Trend 0.09 0.090
Sustainable Growth Rate -7.5% -3.4% -2.5% -2.53%
Internal Growth Rate
Cash Flow Quality
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.53 -27.94 -19.30 -4.66 -5.96 -7.77 10.96 4.22 3.21 3.208
FCF/OCF 4.34 0.28 0.47 0.48 0.62 0.60 0.90 0.76 0.73 0.732
FCF/Net Income snapshot only 2.347
OCF/EBITDA snapshot only 0.888
CapEx/Revenue 4.0% 3.8% 4.1% 4.4% 4.4% 4.7% 1.4% 3.1% 3.6% 3.64%
CapEx/Depreciation snapshot only 0.388
Accruals Ratio 0.00 -0.01 -0.03 -0.05 -0.06 -0.06 -0.06 -0.05 -0.04 -0.045
Sloan Accruals snapshot only 0.139
Cash Flow Adequacy snapshot only 1.252
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 1.1% 2.7% 2.4% 2.8% 3.1% 2.6% 2.3% 2.1% 1.9% 1.99%
Dividend/Share $0.16 $0.38 $0.62 $0.79 $0.92 $0.94 $0.98 $0.98 $0.91 $1.00
Payout Ratio 5.8% 2.3% 1.7% 1.70%
FCF Payout Ratio 3.3% 1.5% 1.4% 96.3% 98.5% 59.1% 72.6% 72.5% 72.53%
Total Payout Ratio 5.8% 2.3% 1.8% 1.80%
Div. Increase Streak 0 0 0 0 1 1 1 1 1 1
Chowder Number 7.70 2.06 0.95 0.37 0.21 0.207
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.11%
Net Buyback Yield -53.2% -42.0% -36.7% -31.8% -13.6% -14.1% -8.7% -14.6% -14.5% -14.47%
Total Shareholder Return -52.0% -39.3% -34.2% -29.0% -10.5% -11.5% -6.4% -12.5% -12.5% -12.55%
DuPont Factors
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.43 -2.16 3.11 1.12 1.09 1.09 3.33 1.43 1.28 1.280
Interest Burden (EBT/EBIT) -0.08 0.01 -0.02 -0.36 -0.49 -0.40 0.10 0.43 0.56 0.561
EBIT Margin 0.07 0.07 0.06 0.05 0.04 0.04 0.04 0.05 0.06 0.059
Asset Turnover 0.11 0.22 0.33 0.46 0.47 0.47 0.49 0.46 0.48 0.478
Equity Multiplier 3.60 3.60 3.60 1.98 2.57 2.57 2.57 1.78 1.78 1.776
Per Share
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.04 $-0.01 $-0.05 $-0.25 $-0.26 $-0.20 $0.17 $0.42 $0.53 $0.53
Book Value/Share $12.18 $9.72 $9.50 $14.71 $14.41 $14.03 $13.88 $19.90 $17.67 $18798.61
Tangible Book/Share $8.20 $6.54 $6.39 $12.13 $11.88 $11.57 $11.45 $16.98 $15.07 $15.07
Revenue/Share $4.79 $7.68 $11.43 $13.47 $13.46 $13.34 $13.50 $13.55 $12.61 $12.65
FCF/Share $-0.25 $0.12 $0.41 $0.55 $0.95 $0.95 $1.65 $1.35 $1.25 $1.26
OCF/Share $-0.06 $0.41 $0.87 $1.15 $1.55 $1.58 $1.83 $1.76 $1.71 $1.72
Cash/Share $0.42 $0.33 $0.32 $0.50 $0.49 $0.48 $0.47 $0.69 $0.61 $637.31
EBITDA/Share $0.85 $1.37 $1.94 $2.05 $1.88 $1.80 $1.80 $1.92 $1.93 $1.93
Debt/Share $28.95 $23.10 $22.58 $12.17 $11.92 $11.61 $11.48 $9.52 $8.45 $8.45
Net Debt/Share $28.53 $22.77 $22.25 $11.67 $11.43 $11.13 $11.01 $8.83 $7.84 $7.84
Academic Models
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.765
Altman Z-Prime snapshot only 4.128
Piotroski F-Score 1 3 3 3 5 5 7 5 6 6
Beneish M-Score -2.68 -2.70 -2.57 74.93 -10.94 -10.942
Ohlson O-Score snapshot only -9.081
ROIC (Greenblatt) snapshot only 23.66%
Net-Net WC snapshot only $-9.29
EVA snapshot only $-257494186.26
Credit
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB+
Credit Score 6.91 9.77 11.31 19.57 26.14 25.54 37.92 52.86 60.71 60.709
Credit Grade snapshot only 8
Credit Trend snapshot only 34.571
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 80
Sector Credit Rank snapshot only 74

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms